Projects funded by the NCN
The group III metabotropic glutamate receptors as a target for future antypsychotic drugs
2012/06/A/NZ7/00014
Keywords:
group III mGlu receptors mGlu4 mGlu8 schizophrenia glutamate serotonin 5-HT1A receptors antypsychotic drugs
Descriptors:
- NZ4_12: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: MAESTRO 3 - announced on 2012-06-15
Amount awarded: 2 861 200 PLN
Project start date (Y-m-d): 2013-05-07
Project end date (Y-m-d): 2019-01-06
Project duration:: 68 months (the same as in the proposal)
Project status: Project settled